Loading...

Daxor Corporation

DXR•NASDAQ
Healthcare
Medical - Instruments & Supplies
$8.75
$-0.04(-0.46%)

Daxor Corporation (DXR) Stock Overview

Explore Daxor Corporation’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
1203.92%
↑ 1203.92%
Profit Growth
$0.11
↑ 91.11%
EPS Growth
$0.11
↑ 81.52%
Operating Margin
248.71%
↓ 601.88%
ROE
1.57%
↑ 91.11%
Dividend Yield
0.00%
Analyst Recommendations data is not available for DXRAnalyst Recommendations details for DXR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

CEO

Mr. Michael Richard Feldschuh

Employees

37

Headquarters

109 Meco Lane, Oak Ridge, TN

Founded

1983

Frequently Asked Questions